We tested the hypothesis that erythropoietin (EPO) enhances bone formation after posterolateral spinal fusion (PLF) in a rabbit model. Thirty-four adult rabbits underwent posterolateral intertransverse arthrodesis at the L5-L6 level using 2.0ag autograft per side. The animals were randomly divided into two groups receiving subcutaneous daily injections of either EPO or saline for 20 days. Treatment commenced 2 days preoperatively. Hemoglobin was monitored at baseline and 2, 4, and 6 weeks after fusion surgery. After euthanasia 6 weeks postoperatively, manual palpation, radiographic, and histomorphometric examinations were performed. Bone volume of the fusion mass was estimated by CT after 6 weeks. EPO increased bone fusion volume to 3.85accm (3.66-4.05) compared with 3.26accm (2.97-3.55) in the control group (pa
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Rölfing, J. H. D., Bendtsen, M., Jensen, J., Stiehler, M., Foldager, C. B., Hellfritzsch, M. B., & Bünger, C. (2012). Erythropoietin augments bone formation in a rabbit posterolateral spinal fusion model. Journal of Orthopaedic Research, 30(7), 1083–1088. https://doi.org/10.1002/jor.22027